Most Recent Posts
This morning, British scientist John Gurdon shared one of two Nobel Prizes awarded this year in physiology and medicine. Dr.
In this month's issue of Psychology Today, there was a good read about the psychological impact of having a rare disease, 'The Loneliest Fight', profiling four patients' experience with very differe
Medicare Today has released its 2012 beneficiary satisfaction survey results today and to put it simply, seniors love Medicare Part D.
Over a decade ago, when SARS (Severe Acute Respiratory Syndrome) was first detected in China, it took significant time to identify the virus and to understand how the disease spread among affected populations.
PhRMA president & CEO John Castellani and Jim Greenwood, president and CEO of the Biotechnology Industry Association (BIO) team-up at Patent Docs to c
Drugfree.org kicked off an amazing campaign to promote consumer awareness of safe medicine use and disposal - if you haven't seen their parent and teacher toolkits, you're missing out. And while their Project's kickoff may be over, our work to reduce prescription drug abuse continues on. In keeping that fire burning, I've asked PDMP Center of Excellence at Brandeis University Director John Eadie to guest blog post about what's going on in their neck of the woods.
In the parlance of corporate mergers, "Day 1" is a critical moment of transition. While not without challenges, Day 1 often brings a sense of excitement, promising growth platforms and long-term opportunities. When it comes to regulatory policy, this marks the biopharmaceutical research sector's Day 1.